Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Bendamustine Hydrochloride
×
1 year
×
Clear all
Filters
3
NCT05139017
2026-03-10
waveLINE-003
Merck Sharp & Dohme LLC
Phase 2/3
Recruiting
290 enrolled
NCT02763319
2025-07-17
B-MIND
Incyte Corporation
Phase 2/3
Completed
453 enrolled
29 charts